Abstract

Point-of-use devices to conveniently deliver protein therapeutics are of growing need. Microneedles offer an approach to deliver biopharmaceuticals across the skin and circumvent syringe-based injection or harsh oral environments. Certain microneedles rapidly dissolve to deliver their payload, while others affix to the skin for sustained release. Here, a microneedle platform combining a PEG-based supramolecular polymer network with a mechanical biopolymer network is able to penetrate the skin, where the microneedles subsequently swell; those composed of supramolecular cross-links detach upon device removal. The embedded supramolecular microneedles afford sustained delivery of insulin for >12 h of blood glucose correction following only 5 min of skin application. Conversion of the supramolecular cross-links to a covalent form prevents microneedle detachment, with brief application failing to correct blood glucose. This approach offers a simple route of fabricating detachable microneedles using polymer formulations with supramolecular bonding, improving on the complex fabrication of previous detachable microneedle designs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call